在CVS Caremark的配方中添加了Zydus生命科学糖尿病药物,以改善患者获得治疗的机会。 Zydus Lifesciences' diabetes drugs added to CVS Caremark's formulary to improve patient access.

Zydus生命科学社与CVS Caremark合作, 将其糖尿病药物Zituvio、Zituvimet和Zituvimet XR添加到CVS2025年1月1日开始的模板配方中。 Zydus Lifesciences has partnered with CVS Caremark to add its diabetes drugs, Zituvio, Zituvimet, and Zituvimet XR, to CVS's template formulary starting January 1, 2025. 这种配方包括现有医学证据和专家判断所支持的药物。 This formulary includes medications backed by current medical evidence and expert judgment. 这些产品含有西塔格利普丁和甲胺,旨在改善患者获得高质量的糖尿病治疗. The products, containing sitagliptin and metformin hydrochloride, aim to improve patients' access to high-quality diabetes treatments.